Role of platelets and complement in the clearance of epimastigote forms of Trypanosoma cruzi.

Braz J Med Biol Res

Laboratório de Imunopatologia, Instituto Butantan, SP, Brasil.

Published: October 1994

1. Trypanosoma cruzi epimastigote forms are very rapidly removed from the circulation of normal and C5-deficient mice. Depletion of C3 by cobra venom factor results in a significant delay in parasite clearance. 2. During parasite clearance there is a significant decrease in the number of circulating platelets and parasite clearance is considerably delayed in thrombocytopenic animals. 3. In vitro incubation of epimastigote forms with normal mouse serum leads to the formation of parasite clumps provided that platelets are present. Inactivation of factor B or depletion of C3 prevents this phenomenon. 4. When epimastigotes are incubated with normal mouse serum they absorb one or more factors required for their aggregation with platelets. 5. It is suggested that in mice T. cruzi epimastigote forms are removed from circulation by the alternative pathway of complement activation and that both C3 and platelets are required for parasite clearance.

Download full-text PDF

Source

Publication Analysis

Top Keywords

epimastigote forms
16
parasite clearance
16
trypanosoma cruzi
8
cruzi epimastigote
8
removed circulation
8
normal mouse
8
mouse serum
8
clearance
5
parasite
5
role platelets
4

Similar Publications

This work investigates the anti-trypanosomal activities of ten thiohydantoin derivatives against the parasite Trypanosoma cruzi. Compounds with aliphatic chains (THD1, THD3, and THD5) exhibited the most promising IC against the epimastigote form of T. cruzi.

View Article and Find Full Text PDF

Chagas disease (CD) is a life-threatening illness caused by the protozoan Trypanosoma cruzi and there are only two drugs currently available for pharmacotherapy of this neglected infection (benznidazole and nifurtimox). Their limited efficacy in chronic phase of the disease, problems of toxicity and the growing resistance by the protozoan are directly associated to high rates of drug discontinuation by the patients. In the context of the search for new trypanocidal drug candidates, our group has been working with the chemical manipulation of eugenol to obtain new agents active against T.

View Article and Find Full Text PDF

The protozoan parasite is the causative agent of Chagas disease, also called American trypanosomiasis. This neglected tropical disease affects millions of individuals across the Americas. To complete its life cycle, parasitizes both vertebrate hosts and its vector, commonly known as the 'kissing bug'.

View Article and Find Full Text PDF

A comprehensive review of arginine kinase proteins: What we need to know?

Biochem Biophys Rep

December 2024

Universidade Federal do Rio de Janeiro, Instituto de Química, 21941-909, Rio de Janeiro, RJ, Brazil.

The enzyme arginine kinase (AK), EC 2.7.3.

View Article and Find Full Text PDF

Branched-chain amino acids modulate the proteomic profile of Trypanosoma cruzi metacyclogenesis induced by proline.

PLoS Negl Trop Dis

October 2024

Laboratory of Biochemistry of Tryps - LaBTryps - Department of Parasitology, Instituto de Ciências Biomédicas II, Universidade de São Paulo, São Paulo, Brazil.

Trypanosoma cruzi, the causative agent of Chagas disease, has a complex life cycle that involves triatomine insects as vectors and mammals as hosts. The differentiation of epimastigote forms into metacyclic trypomastigotes within the insect vector is crucial for the parasite's life cycle progression. Factors influencing this process, including temperature, pH, and nutritional stress, along with specific metabolite availability, play a pivotal role.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!